Nathaniel Brown
Impact in
- Hepatology top 0.1%
- Hepatitis C virus research
- Hepatitis Viruses Studies and Epidemiology
- Epidemiology top 0.1%
- Hepatitis B Virus Studies
- Liver Disease Diagnosis and Treatment
- Cytomegalovirus and herpesvirus research
Papers in
- Epidemiology 55
- Hepatitis B Virus Studies 48
- Liver Disease Diagnosis and Treatment 16
- Hepatology 48
- Hepatitis C virus research 47
- Co-authors
- Lynn D. Condreay (9 shared papers)Eugene R. Schiff (13 shared papers)Jules L. Dienstag (12 shared papers)Ching‐Lung Lai (23 shared papers)Mary Woessner (7 shared papers)Zachary Goodman (4 shared papers)Teresa L. Wright (6 shared papers)Robert G. Gish (4 shared papers)
- Journals
- Journal of Hepatology (27 papers)Gastroenterology (7 papers)Hepatology (6 papers)Antimicrobial Agents and Chemotherapy (4 papers)New England Journal of Medicine (3 papers)
- Partner nations
- United StatesChinaCanada
In The Last Decade
Nathaniel Brown
87 papers receiving 7.0k citations
Nathaniel Brown's Hit Papers
Peers
Comparison fields: 5 of 118
- Hepatology 4.3k
- Epidemiology 6.1k
- Infectious Diseases 1.3k
- Virology 101
- Neurology 283
Countries citing papers authored by Nathaniel Brown
This map shows the geographic impact of Nathaniel Brown's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nathaniel Brown with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nathaniel Brown more than expected).
Fields of papers citing papers by Nathaniel Brown
This network shows the impact of papers produced by Nathaniel Brown. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nathaniel Brown. The network helps show where Nathaniel Brown may publish in the future.
Co-authors
The 25 scholars most cited alongside Nathaniel Brown, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 91 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Lamivudine as Initial Treatment for Chronic Hepatitis B in the United States Hit paper breakdown → | 1999 | 1019 |
| 2 | Identification and characterization of mutations in hepatitis B virus resistant to lamivudine Hit paper breakdown → | 1998 | 701 |
| 3 | Telbivudine versus Lamivudine in Patients with Chronic Hepatitis B Hit paper breakdown → | 2007 | 606 |
| 4 | Prevalence and Clinical Correlates of YMDD Variants during Lamivudine Therapy for Patients with Chronic Hepatitis B Hit paper breakdown → | 2003 | 518 |
| 5 | 2008 | 450 | |
| 6 | 1997 | 405 | |
| 7 | 2005 | 324 | |
| 8 | 2001 | 320 | |
| 9 | 2002 | 248 | |
| 10 | 1999 | 220 | |
| 11 | 2008 | 202 | |
| 12 | 2002 | 194 | |
| 13 | 1999 | 167 | |
| 14 | 2008 | 147 | |
| 15 | 1982 | 144 | |
| 16 | 2001 | 141 | |
| 17 | 1980 | 128 | |
| 18 | 2019 | 121 | |
| 19 | 1999 | 108 | |
| 20 | 2003 | 100 |
About Nathaniel Brown
Nathaniel Brown is a scholar working on Epidemiology, Hepatology, Infectious Diseases, Pathology and Forensic Medicine and Oncology, having authored 91 papers that have together received 7.4k indexed citations. Recurring topics across this work include Hepatitis B Virus Studies (48 papers), Hepatitis C virus research (47 papers), HIV/AIDS drug development and treatment (24 papers), Liver Disease Diagnosis and Treatment (16 papers), Lymphoma Diagnosis and Treatment (7 papers), Viral-associated cancers and disorders (6 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Parvovirus B19 Infection Studies (5 papers). The work is most often cited by research in Hepatology (4.3k citations), Epidemiology (6.1k citations), Infectious Diseases (1.3k citations), Virology (101 citations) and Neurology (283 citations). Nathaniel Brown has collaborated with scholars based in United States, China and Canada. Frequent co-authors include Lynn D. Condreay, Eugene R. Schiff, Jules L. Dienstag, Ching‐Lung Lai, Mary Woessner, Zachary Goodman, Teresa L. Wright, Robert G. Gish, George Chao and David Tyrrell. Their work appears in journals such as Journal of Hepatology, Gastroenterology, Hepatology, Antimicrobial Agents and Chemotherapy and New England Journal of Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.